Early neonatal death due to prenatally undiagnosed congenital subglottic stenosis in Noonan syndrome Authors: Maolee Bhuwapathanapun, Supakorn Chaiyakarn, Atcharaporn Pongtippan, Sirawich Arunotai, Piya Chaemsaithong, Puntabut Warintaksa, Patama Promsonthi, Saisuda Noojarern, Duangrurdee Wattanasirichaigoon Published: 2026 ABSTRACT IntroductionCongenital subglottic stenosis is a rare malformation of the laryngeal airway. In its severe forms, it can result in immediate neonatal respiratory failure and death if not managed emergently at birth.Case presentationA pregnant woman, whose fetus was suspected of having Noonan syndrome, underwent a cesarean delivery. Notably, subglottic stenosis was not detected on prenatal imaging. The neonate exhibited immediate and severe respiratory distress, and upper airway obstruction was diagnosed during neonatal resuscitation, leading to failed intubation and subsequent neonatal demise. The post-mortem examination revealed cartilaginous subglottic stenosis and type C tracheoesophageal (TE) fistula. Exome sequencing identified a de novo, c.923 A>G, PTPN11 pathogenic variant.ConclusionThe pitfalls in prenatal diagnosis and genetic counseling could raise awareness of possible lethal upper airway obstruction in Noonan syndrome patients. Comprehensive prenatal evaluation and diagnosis are critical to ensuring appropriate neonatal resuscitation. Introduction Congenital subglottic stenosis is a rare congenital anomaly characterized by lumen constriction below the glottis and above the first tracheal ring, typically defined as a subglottic diameter of less than 4.0 mm at the cricoid level in a term newborn [1]. It belongs to the broader spectrum of congenital laryngeal malformations, along with laryngomalacia and vocal cord anomalies [2]. Although acquired subglottic stenosis (secondary to intubation) is more common, the congenital form requires early recognition because of the acute risk of severe airway obstruction and early neonatal demise in severe cases, in which the lumen is almost completely obstructed. This report describes a case of prenatally undiagnosed congenital subglottic stenosis, genetic etiology, and challenges in prenatal diagnosis. Case report/case presentation A 35-year-old primigravida was referred to the Maternal-Fetal-Medicine Unit, Ramathibodi Hospital at 27 weeks of gestation following the detection of a depressed fetal sternum, despite an unremarkable mid-trimester scan. Chromosomal microarray analysis (CMA) via amniocentesis was normal. A detailed ultrasonography at 29 weeks confirmed fetal pectus excavatum (Fig. 1), dilated lateral ventricles and a thin corpus callosum, and facial dysmorphism characterized by low-set ears and prenasal skin thickening. While the stomach size and lung echogenicity appeared normal, a fetal echocardiogram revealed hypertrophic cardiomyopathy (HCM) without infundibular or pulmonary valve stenosis, a dilated coronary sinus, and a persistent left superior vena cava. Polyhydramnios was also noted, with an amniotic fluid index of 26 cm. The presence of pectus excavatum, facial dysmorphism, and congenital heart defects raised the suspicion of Noonan syndrome. After a comprehensive discussion with the family, they elected to continue the pregnancy, as the identified anomalies were considered generally non-lethal. Due to the advanced gestational age, diagnostic exome sequencing was deferred to the postnatal period. Fig. 1Ultrasound of a fetus affected with PTPN11 c.923 A>G. 3D ultrasound of the coronal view of the fetal thorax at 29 weeks gestation revealed pectus excavatum with a depressed sternum Ultrasound of a fetus affected with PTPN11 c.923 A>G. 3D ultrasound of the coronal view of the fetal thorax at 29 weeks gestation revealed pectus excavatum with a depressed sternum At 33 weeks of gestation, the patient presented with preterm premature rupture of membranes (PPROM). Tocolytic agents and antenatal corticosteroids were given to promote lung maturity. However, the patient developed clinical chorioamnionitis at 34 weeks, and an emergency cesarean delivery was performed for a nonreassuring fetal heart pattern. The female neonate was delivered weighing 2230 g. APGAR scores were 1, 1, and 0 at 1, 5, and 10 min, respectively. During resuscitation, direct laryngoscopy intubation failed to pass the vocal cord; despite several attempts, even the smallest available endotracheal tube (2.5 mm) could not pass the vocal folds. The neonate was pronounced dead after 30 min of neonatal resuscitation. Postmortem examination revealed several dysmorphic features: overfolded helices, a thin upper lip, pectus excavatum, and imperforate anus. The head circumference was 33 cm (> 90th percentile). Cord blood was collected for whole-exome sequencing (WES), and an autopsy was performed with parental informed consent. Autopsy findings confirmed hypoplasia of the corpus callosum and concentric hypertrophy of the right ventricle with bilateral superior vena cava, while lungs, kidneys, and spines appeared unremarkable. Notably, evaluation of the upper airway revealed subglottic stenosis, with a lumen narrowed to 0.1 cm (Fig. 2) due to the posterior part of the cricoid cartilage encroaching into the laryngeal lumen. Additionally, segmental esophageal atresia with a distal tracheoesophageal (TE) fistula (Type C) was identified. Trio WES, followed by Sanger sequencing, confirmed a de novo heterozygous PTPN11 variant (c.923 A>G p.Asn308Ser). This variant is a well-documented pathogenic mutation associated with RASopathies, including Noonan syndrome. Fig. 2Gross pathology of a fetus affected with PTPN11 c.923 A>G. The lower part of the trachea is identified by a ring of cartilage structure with the small orifice of the trachea compatible with subglottic stenosis Gross pathology of a fetus affected with PTPN11 c.923 A>G. The lower part of the trachea is identified by a ring of cartilage structure with the small orifice of the trachea compatible with subglottic stenosis Methods Trio-WES and bioinformatics analysis Informed consent for genetic analysis was obtained from the parents. Genomic DNA was extracted from the neonate’s umbilical cord blood and parental peripheral blood samples using standard protocols. WES was performed on an Illumina HiSeq 4000 sequencer. The reads were aligned to the human reference sequence (GRCh37) via the Burrows–Wheeler Aligner (BWA), and variants were identified via the Genomic Analysis Tool Kit (GATK). Candidate variants are those with minor allele frequencies < 5% in 1000 Genomes. Each variant is evaluated on the basis of the multiple genomic resources (HGMD, ClinVar, 1000 Genomes, and dbSNP), and its predicted functional or splicing impact via evolutionary conservation analysis and computational tools (including NNSPLICE, PolyPhen-2, and SIFT). Further assessment included a review of published literature, clinical correlation with the patient’s phenotype, and segregation analysis. The positive variant suspected to explain the phenotype was confirmed via Sanger sequencing. Discussion Congenital subglottic stenosis is a rare entity with an unknown population prevalence. Available data suggest it accounts for approximately 1–5% of all subglottic stenosis cases, with most cases being acquired [3]. Unlike the trachea, the subglottic airway is a complete, non-expendable, and non-pliable cartilaginous ring, making it the narrowest portion of the neonatal airway. Severe congenital subglottic stenosis typically manifests shortly after birth as acute dyspnea and respiratory difficulty. Esophageal malformations are frequently associated with subglottic stenosis, as both arise from incomplete septation and recanalization during foregut organogenesis. Prenatal ultrasound diagnosis of subglottic stenosis is difficult, although certain identifiable cases may demonstrate bilateral hyperechoic lungs, an inverted diaphragm, and dilatation of the proximal airways, indicating congenital high airway obstruction (CHAOS). Esophageal atresia may present with an absent/small stomach, potentially detected by ultrasound. However, prenatal diagnosis findings were not observed in this fetus, probably because air and airway secretions were drained into the stomach via the TE fistula, as a compensatory mechanism described by Sato et al. [4]. In this case, prenatal chromosomal microarray analysis (CMA) was unremarkable. While CMA is recommended as a first-line test for fetuses with structural anomalies, whole exome sequencing (WES) should be considered when a monogenic disorder is suspected or when initial tests are non-diagnostic [5]. Although a definitive molecular diagnosis is important for guiding postnatal management and informing recurrence risk, the clinical utility of prenatal WES in late-gestation cases may be hindered by its turnaround time. To our knowledge, this is the first reported case of Noonan syndrome presenting with subglottic stenosis caused by a PTPN11 mutation. PTPN11 variants are the most common genetic mutations underlying Noonan syndrome and other RASopathies, which exhibit significant variable expressivity [6]. While the common phenotype includes distinctive facial features, congenital heart defects, and chest and spine deformities, notably, TE fistula and subglottic stenosis have never been reported [7–11]. However, various phenotypes of Noonan syndrome can be explained by the upregulation of SHP-2, a PTPN11 encoded protein that regulates cell proliferation, differentiation, migration, and apoptosis during embryonic development via the RAS‒MAPK signaling pathway [12]. Mild polyhydramnios can be observed in normal fetuses. However, this feature can be found in almost 50% of fetuses with RASopathies [13]. A recent study revealed that 11.5% (15 out of 131) of pregnancies complicated with polyhydramnios were associated with fetal RASopathies [14]. Given the limitations of prenatal ultrasound in visualizing upper airway and esophageal structures, fetal MRI should be considered an alternative investigation, as its accuracy is not affected by fetal position or polyhydramnios. The pitfalls learned from the present case could raise awareness of possible lethal upper airway obstruction in Noonan syndrome/RASopathies. The presence of polyhydramnios might be an essential clue for upper airway obstruction. Furthermore, airway management in Noonan syndrome can be complicated by associated features such as a webbed neck or cervical spine anomalies. Prenatal diagnosis of such anomalies, together with special preparation for neonatal resuscitation are therefore essential for intrapartum management. One of the most suggestive procedures for fetal upper airway obstruction is the ex utero intrapartum treatment (EXIT) procedure, which allows establishment of a secure airway, including laryngoscopy or tracheostomy, while maintaining feto–placental circulation [15].